Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

Two Small Series Support Role for Cerebral Protection in TAVR

Michael O'Riordan

November 18, 2019

News Daily News

Gaps in Access to TAVR and SAVR: ‘Something Needs to Be Done’

L.A. McKeown

October 29, 2019

News Daily News

New-Onset A-fib Tied to Particularly Poor Outcomes After TAVR

Todd Neale

October 18, 2019

News Daily News

Drug Abuse in Infective Endocarditis Patients Spikes Amid US Opioid Epidemic

Caitlin E. Cox

October 02, 2019

News Conference News TCT 2019

Long-term PARTNER 2A Results Put Spotlight on Paravalvular Leak in TAVR

Todd Neale

September 29, 2019

News Daily News

FDA Expands TAVR Indication to Low-Risk Patients

Michael O'Riordan

August 16, 2019

News Features

Structural Heart Hype: As Fellowship Programs Mushroom, Who’s Keeping Tabs on Quality and Numbers?

Yael L. Maxwell

August 02, 2019

News Daily News

TAVR Growing in the US, but Vast Majority of Patients Not Receiving Any Form of Valve Replacement

Michael O'Riordan

June 12, 2019

News Daily News

FDA Approves Lotus Edge, Ushering Third Device Into US Market

Shelley Wood

April 24, 2019

News Daily News

Signal of Aortic Stenosis Risk With Celecoxib

Michael O'Riordan

March 05, 2019

News Conference News STS 2019

Redo Surgery for Bioprosthetic Aortic Valve Failure on the Decline Since 2015

Yael L. Maxwell

February 06, 2019

News Daily News

NOTION and UK TAVI Report Good Long-term Function of Transcatheter Aortic Valves

L.A. McKeown

February 06, 2019

News Daily News

Cancer Patients Should Not Be Automatically Ruled Out for TAVR: Analysis

L.A. McKeown

January 10, 2019

News Daily News

Continuing Anticoagulation During TAVR in A-fib Patients May Be Safe, Study Suggests

Todd Neale

January 09, 2019

Advertisement

Two Small Series Support Role for Cerebral Protection in TAVR

Gaps in Access to TAVR and SAVR: ‘Something Needs to Be Done’

New-Onset A-fib Tied to Particularly Poor Outcomes After TAVR

Drug Abuse in Infective Endocarditis Patients Spikes Amid US Opioid Epidemic

Long-term PARTNER 2A Results Put Spotlight on Paravalvular Leak in TAVR

FDA Expands TAVR Indication to Low-Risk Patients

Structural Heart Hype: As Fellowship Programs Mushroom, Who’s Keeping Tabs on Quality and Numbers?

TAVR Growing in the US, but Vast Majority of Patients Not Receiving Any Form of Valve Replacement

FDA Approves Lotus Edge, Ushering Third Device Into US Market

Signal of Aortic Stenosis Risk With Celecoxib

Redo Surgery for Bioprosthetic Aortic Valve Failure on the Decline Since 2015

NOTION and UK TAVI Report Good Long-term Function of Transcatheter Aortic Valves

Cancer Patients Should Not Be Automatically Ruled Out for TAVR: Analysis

Continuing Anticoagulation During TAVR in A-fib Patients May Be Safe, Study Suggests

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content